Key result
Cardiovascular magnetic resonance imaging with late gadolinium enhancement detects cardiac fibrosis, serving as a potential tool for risk stratification of sudden cardiac death in non-ischemic dilated cardiomyopathy.
Why the study?
Does cardiovascular magnetic resonance (CMR) imaging with Late Gadolinium Enhancement (LGE) improve risk stratification for sudden cardiac death in patients with non-ischemic dilated cardiomyopathy?
Does cardiovascular magnetic resonance (CMR) imaging with Late Gadolinium Enhancement (LGE) improve risk stratification for sudden cardiac death in patients with non-ischemic dilated cardiomyopathy?
CMR with LGE is a promising non-invasive tool for detecting myocardial fibrosis to improve risk stratification for sudden cardiac death and guide ICD implantation in patients with non-ischemic dilated cardiomyopathy.
May support LGE fibrosis detection for SCD risk stratification in NIDCM; leaves open prospective validation before guiding ICD decisions.
The use of cardiovascular magnetic resonance (CMR) imaging for assessing and evaluating cardiovascular pathologies is growing rapidly. This non-invasive, non-ionizing technology has multiple advantages compared with the X-ray or gamma ray derived technologies. For instance, CMR is a non-invasive and sensitive tool for detecting islands of fibrosis. Cardiac fibrosis may occur in both ischemic and non-ischemic cardiac pathologies.This finding has a negative impact on sudden cardiac arrhythmic death. A correlation has been found between CMR data and histo-pathologic findings. The presence of this pathology among normal looking fibers indicates the presence of non-functional areas that may evoke malignant arrhythmia, and contribute to deterioration in cardiac mechanical function. By using this non-invasive modality, the role of cardiac fibrosis as a potential source for cardiac arrhythmia and or LV dysfunction can be better evaluated and managed. This finding may serve as a useful tool for risk stratification of patients with borderline indication for primary AICD implantation.
No takes yet. Share an insight, caveat, or question.
Malka Yahalom Yoav Turgeman (2014) conducted a review in Non-Ischemic Dilated Cardiomyopathy. Cardiac Magnetic Resonance (CMR) Imaging was evaluated. Cardiovascular magnetic resonance imaging with late gadolinium enhancement detects cardiac fibrosis, serving as a potential tool for risk stratification of sudden cardiac death in non-ischemic dilated cardiomyopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: